1 – 10 of 25
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Elevated carbohydrate antigen 125 (CA125) is associated with incident heart failure and mortality in acute coronary syndrome
(
- Contribution to journal › Article
-
Mark
The Gly82Ser polymorphism in the receptor for advanced glycation endproducts increases the risk for coronary events in the general population
(
- Contribution to journal › Article
- 2023
-
Mark
Elevated soluble LOX-1 predicts risk of first-time myocardial infarction
(
- Contribution to journal › Article
-
Mark
Invariant natural killer T cells and incidence of first-time coronary events : a nested case-control study
(
- Contribution to journal › Article
-
Mark
Therapeutic S100A8/A9 blockade inhibits myocardial and systemic inflammation and mitigates sepsis-induced myocardial dysfunction
(
- Contribution to journal › Article
- 2020
-
Mark
S100A9 Links Inflammation and Repair in Myocardial Infarction
(
- Contribution to journal › Article
- 2019
-
Mark
High Plasma sRAGE (Soluble Receptor for Advanced Glycation End Products) Is Associated With Slower Carotid Intima-Media Thickness Progression and Lower Risk for First-Time Coronary Events and Mortality
(
- Contribution to journal › Article
-
Mark
Elevated IL-27 in patients with acute coronary syndrome is associated with adverse ventricular remodeling and increased risk of recurrent myocardial infarction and cardiovascular death
(
- Contribution to journal › Article
-
Mark
Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke : Meta-Analysis of Population-Based Studies Involving 17 180 Individuals
(
- Contribution to journal › Article
-
Mark
The soluble receptor for advanced glycation end-products (sRAGE) has a dual phase-dependent association with residual cardiovascular risk after an acute coronary event.
(
- Contribution to journal › Article